A winning line-up of strategists and implementers...

This is a meeting where real progress happens. So we've carefully handpicked and confirmed 41 people so far, based solely on recommendations and reputations. The list of attendees is growing at between 15 and 20 people each week. Come back in a few days for more updates. 

Confirmed so far:

  • Robert Urban, Global Head, Johnson & Johnson Innovation, Johnson & Johnson
  • John Methot, Director, Health Informatics Architecture, Dana Farber Cancer Institute
  • Bipin Karunakaran, VP, Enterprise Data Management, Geisinger Health System
  • Chandra Sekhar Pedamallu, NGS pipeline Lead, Sanofi
  • Artur Veloso, Investigator II, Oncology Bioinformatics, Novartis Institutes for BioMedical Research
  • Gregory Hinkle, Director, Research Informatics and Genomics, Alnylam Pharmaceuticals
  • Adrian Gropper, CTO, Patient Privacy Rights
  • Matthew Kennedy, Director, Neuroscience, Merck Research Labs
  • Monica Wang, Principal Bioinformatics Architect, Takeda Oncology
  • Xiang Chen, Assistant Member, Department of Computational Biology, St. Jude's Children's Research Hospital
  • Pablo Cingolani, Principal Scientist, AstraZeneca
  • David Orlando, Principal Scientist, Computational Biology, Syros Pharmaceuticals
  • Kevin Hughs, Medical Director, Mass General Hospital
  • Liz Worthey, Director, Software Development & Informatics, HudsonAlpha Institute for Biotechnology
  • Niloofar Jalali, Research Fellow in Biomedical Informatics, Harvard Medical School
  • Catherine Del Vecchio Fitz, Senior Research Scientist, Clinical Genomics, Dana Farber Cancer Institute
  • David Siedzik, Associate Director, Portfolio and Engagement Strategy, Data Sciences Platform, Broad Institute of Harvard and MIT
  • Iain Wallace, Data development, Scientific Information Management, Merck
  • Will Chen, Director of computational and systems biology , Biogen
  • Ingrid  A. Holm,  Associate Professor of Paediatrics, Harvard Medical School
  • David Smith, Professor of Laboratory Medicine and Pathology, Mayo Clinic
  • Matt Ducar, Associate director of CCGD/PROFILE informatics, Dana-Farber Cancer Institute
  • John (Mike) Furgason, Bioinformatician, Division of Biomedical Informatics, Cincinnati Children's Hospital
  • Matt Stachler, BWH pathology, BWH
  • Jochen (Joe) Lennerz, Associate Director, Center for Integrated Diagnostics, Massachusetts General Hospital  
  • Diane Joseph-McCarthy, Vice President, Translational Science, Enbiotix
  • Agustin Chicas, Head of Genomic Target Discovery and Validation, Forma Therapeutics
  • Matthew Eaton, Principal Scientist, Computational Biology, Syros Pharmaceuticals
  • Renato Umeton, Head of Data Science, Dana-Farber Cancer Institute
  • Brad Chapman,  Senior Research Scientist, Harvard University
  • Nathanael Fillmore, Associate Director for Machine Learning and Predictive Analytics MAVERIC, VA Boston Healthcare System
  • Mark Kon, Professor of Mathematics and Statistics, Boston University
  • Adem Albayrak, Product Lead, DFCI Informatics, Dana-Farber Cancer Institute
  • Heming Xing, Senior Principal Scientist, Precision Immunology Cluster, Sanofi
  • Sridevi Ponduru, Associate Medical Director, Takeda Pharmaceutical
  • Mark Aquino, Data Scientist II, AbbVie
  • Michelle Penny, Senior Director, Head of Translational Genome Sciences, Biogen
  • Jennifer Wortman, Senior Director of Bioinformatics, Seres Therapeutics
  • Aaron Day-Williams, Director of Quantitative Target Sciences, Merck
  • Sharon Shechter, Principal Investigator, Silicon Therapy
  • Hans Winkler, Independent Consultant
  • John Methot, Director, Health Informatics Architecture, Dana Farber Cancer Institute
  • Laura   Rasmussen-Torvik, Assistant Professor, Department of Preventive Medicine Northwestern University Feinberg School of Medicine